Keyphrases
Preeclampsia
99%
Surabaya
54%
Indonesia
48%
Maternal Outcomes
40%
Tertiary Referral Hospital
31%
Pregnant Women
31%
General Hospital
29%
Maternal Death
28%
Medical Records
23%
Perinatal Outcome
23%
Obstetrics
22%
Neonatal Outcome
22%
Arginine
20%
Mouse Model
20%
Placenta Accreta Spectrum
20%
Maternal Mortality
20%
COVID-19
20%
Gestational Diabetes Mellitus
19%
During Pregnancy
19%
Early Onset
17%
Magnesium Sulfate
15%
Fetal Outcome
15%
Cardiovascular Risk
14%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
13%
Magnesium Sulfate Therapy
13%
Aortic Cross-clamping
13%
Rapid Antigen Test
13%
Ischemia-reperfusion Injury
13%
Abdominal Aortic
13%
Hypertension
13%
Perinatal Death
12%
Serum Levels
12%
Nifedipine
12%
Obesity in Pregnancy
12%
Obstetrics and Gynaecology
11%
Heart Disease in Pregnancy
11%
Late-onset
11%
Obesity
11%
Methyldopa
11%
Mode of Delivery
10%
Body Mass Index
10%
Antibody Test
9%
Retrospective Cohort Study
9%
Pregnant Rats
9%
Obstetric Emergencies
9%
Treatment Group
9%
Cesarean Hysterectomy
9%
Magnesium
8%
Obese Pregnant Women
8%
Gestational Age
8%
Medicine and Dentistry
Pre-Eclampsia
100%
Patient Referral
32%
Obstetrics
29%
Maternal Death
29%
Cesarean Section
25%
Placenta Accreta
23%
Medical Record
23%
Arginine
20%
Magnesium Sulfate
20%
Eclampsia
20%
Obstetric Emergency
17%
Immunoassay
14%
Diabetes Mellitus
13%
Aortic Clamping
13%
Cardiovascular Risk
13%
Reperfusion Injury
13%
Nifedipine
13%
Maternal Mortality
13%
Magnesium
13%
Apgar Score
13%
Methyldopa
12%
Blood Pressure
11%
Heart Disease
11%
Hypertension
11%
Metabolic Syndrome
11%
Body Mass Index
11%
Premature Labor
11%
Prematurity
11%
Retrospective Study
11%
Perinatal Death
10%
Gestational Diabetes
10%
Placenta
10%
Pregnancy
10%
Gestational Age
9%
Hysterectomy
9%
Retrospective Cohort Study
9%
Outpatient
8%
Macrosomia
8%
Umbilical Artery
8%
Gestational Hypertension
8%
Lymphocyte
8%
Birth Weight
8%
Congenital Malformation
7%
Third Trimester Pregnancy
7%
Cardiovascular Disease
7%
Diseases
7%
Diabetes
7%
Fibrinogen
6%
Platelet
6%
Antihypertensive Agent
6%